BIO boosts lobbying efforts in Q1

Closing in on a 12-year market haven for biologics, the Biotechnology Industry Organization spent $2.2 million lobbying lawmakers in the first quarter. That's up 15 percent from the $1.9 lobbying bill it faces for the same period a year ago, but you won't hear anyone at BIO complaining about what they helped achieve with their push in Washington, D.C. Report